TY  - GEN
AU  - Holgate,S T
AU  - Chuchalin,A G
AU  - Hébert,J
AU  - Lötvall,J
AU  - Persson,G B
AU  - Chung,K F
AU  - Bousquet,J
AU  - Kerstjens,H A
AU  - Fox,H
AU  - Thirlwell,J
AU  - Cioppa,G Della
TI  - Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
SN  - 0954-7894
PY  - 2004///0720
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Androstadienes
KW  - administration & dosage
KW  - Anti-Asthmatic Agents
KW  - adverse effects
KW  - Antibodies, Anti-Idiotypic
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Asthma
KW  - drug therapy
KW  - Bronchodilator Agents
KW  - Child
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fluticasone
KW  - Humans
KW  - Immunoglobulin E
KW  - immunology
KW  - Male
KW  - Middle Aged
KW  - Omalizumab
KW  - Quality of Life
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2222.2004.1916.x
ER  -